Clinical trial
Safety and Efficacy of Fecal Microbiota Transplantation: A Pilot Study
NCT04014413 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Fecal Microbiota Transplantation: A Pilot Study
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 15, 2019
- Completion date
- October 31, 2030
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence, alopecia, atopy or allergy, autism, carbapenem-resistant enterobacteriaceae infection, celiac disease, clostridium difficile infection, constipation, crohn disease, diabetes mellitus, dysbiotic bowel syndrome, functional dysphonia, graft-versus-host disease, hepatic encephalopathy, idiopathic thrombocytopenic purpura, irritable bowel syndrome, liver disease, mrsa enteritis, multidrug -resistant infection, multiple organ dysfunction syndrome, multiple sclerosis, obesity, pseudo-obstruction, pseudomembranous enterocolitis, psoriatic arthropathy, ulcerative colitis, vancomycin resistant enterococci infection